Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral, Coldrex and Lemsip.
Read the report at
The substantial growth of the market from $55 billion in 2017 to nearly $71 billion by 2021 is due to the rise in global air pollution levels which will lead to higher number of respiratory diseases.
In the report, the global respiratory drugs market is divided into two segments, namely, anti-asthmatics and COPD drugs and cough and cold preparations. While the first segment accounts for more than three-fifth of the market and the remaining share is accounted for the other segment.
Download a sample of the report at
The USA was the largest country in the respiratory diseases drugs market in 2017, accounting for nearly two-fifth of the market share. This can be attributed to the large number of patients suffering from asthma and chronic obstructive pulmonary diseases (COPD).
The respiratory drugs market is fragmented with a number of small drug organizations. The top five competitors in the market made up nearly 50% of the total market in 2017. GlaxosmithKline Plc. was the largest competitor of the market, followed by AstraZeneca Plc., Merck & Co, Novartis AG and Johnson & Johnson. GlaxosmithKline Plc. was founded in 1715 and is headquartered in Brentford, UK. It is involved in creating, discovering, developing, manufacturing, and marketing of vaccines, over-the-counter medicines, and health-related consumer products globally.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]